Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ridiculous discussion!

I think what Ease, Brian, and others are driving at is ACCOUNTABILITY by the Board......Now, obviously shareholders are not privy to the decision-making process, such that it exists. We (Shareholders) can only judge the correctness of the decision later on. Over the course of several years enough bad decisions (to the Retail Shareholders) have been rendered by the current slate to develop an informed opinion by most shareholders. OF course hindsight is 20/20 vision. Regardless, we need more forward-thinking people making decisions that effect us all.

Given the prior actual voting records at the last two annual shareholders meeting to remove any or all current Board members, may I suggest the Board simply be enlarged to isolate the 3 amigos. I could envision a scenario whereby RG asks the Board be enlarged to recruit special talent to open doors for PTSC.

Currently, RG does not have the ammo to make such a request. However, IF the re-exams are successful (148 & 336 emerge substantially unchanged or even strengthened), several new licensees, current JV in Homeland Security takes off, etc, ....and the SP is at least $1.00 and stable ( RG option trigger), then I could see RG put forth a proposal to enlarge the Board in order to grow the business and meet with a favorable response from the Board and/or added to the next year's Proxy for approval by all retail shareholders.

Virt

Share
New Message
Please login to post a reply